Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

34.75p
   
  • Change Today:
      0.25p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 73,412
  • Market Cap: £125.61m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-23 Interim 15.70 (13.20) (4.00)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (17.58) (15.42)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.17 (30.98) (14.48)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 32.71 (22.73) (5.80)p n/a n/a n/a n/a 0.0%
31-Dec-24 40.58 (14.30) (3.22)p n/a n/a n/a n/a 0.0%
31-Dec-25 53.70 n/a (0.70)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

CREO Market Data

Currency UK Pounds
Share Price 34.75p
Change Today 0.25p
% Change 0.72 %
52 Week High 48.10
52 Week Low 23.25
Volume 73,412
Shares Issued 361.48m
Market Cap £125.61m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.92% below the market average20.92% below the market average20.92% below the market average20.92% below the market average20.92% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Price Trend
0.06% above the market average0.06% above the market average0.06% above the market average0.06% above the market average0.06% above the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average
Income Not Available
Growth
41.28% above the market average41.28% above the market average41.28% above the market average41.28% above the market average41.28% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
17:08 15,000 @ 34.75p
15:38 285 @ 34.99p
14:20 15,000 @ 34.70p
14:20 2 @ 35.00p
14:20 119 @ 34.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page